Search
Agilent Technologies Inc
AAdd to Watchlist
127.060USD
+2.790+2.24%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
35.86BMarket Cap
27.93P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Agilent Technologies Inc is 7.91, ranking 115 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 167.50, with a high of 185.00 and a low of 149.86.
Analyst Rating
Based on
23
analysts
Buy
Current Rating
160.514
Target Price
+26.33%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
94
Total
3
Median
7
Average
Company name
Ratings
Analysts
Agilent Technologies Inc
A
23
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Agilent Technologies Inc's expected revenue for the next quarter?
Agilent Technologies Inc's expected revenue is 1.84B.
What is Agilent Technologies Inc's price target?
Analysts forecast that Agilent Technologies Inc's price target is USD 167.50, with the highest forecast at USD 185.00 and the lowest forecast at USD 149.86.
How have Agilent Technologies IncA's recent earnings per share performed?
The market expectation was USD 1.20, while Agilent Technologies IncA's earnings per share (EPS) for the previous quarter was USD 1.08. EPS for the next quarter is expected at USD 1.49.
What is the analyst rating for Agilent Technologies Inc?
Based on the ratings of Agilent Technologies Inc's stock from 23 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
